Biomolecular NMR Assignments

, Volume 12, Issue 1, pp 145–148 | Cite as

Backbone and side-chain chemical shift assignments of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1)

  • Xiaofang Ma
  • Yingying Zhang
  • Bin Liu
  • Jiahui YangEmail author
  • Kaifeng HuEmail author


Receptor tyrosine kinase-like orphan receptor 1 (ROR1) expresses at high level in many cancers and has been suggested as a potential therapeutic target. It was reported that the Kringle (KNG) domain of ROR1 extracellular region is involved in ROR1/ROR2 heterooligomerization. Monoantibodies that target KNG domain of ROR1 could induce apoptosis of chronic lymphocytic leukemia cells. Here we present the backbone and side chain assignments of KNG domain of ROR1, which lays a foundation for its further structural and function research.


ROR1 Kringle NMR 



This work was supported by the National Key Research and Development Program of China (No. 2017YFC0906903), the National Natural Science Foundation of China (No. 81401904, 31400642) and Yunnan Provincial Science and Technology Department (No. 2015FB170).

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.


  1. Battistel MD, Grishaev A, An SS, Castellino FJ, Llinas M (2009) Solution structure and functional characterization of human plasminogen kringle 5. Biochemistry 48:10208–10219. CrossRefGoogle Scholar
  2. Daneshmanesh AH et al (2012) Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells. Leukemia 26:1348–1355. CrossRefGoogle Scholar
  3. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6:277–293CrossRefGoogle Scholar
  4. Fernandez NB et al (2016) ROR1 contributes to melanoma cell growth and migration by regulating N-cadherin expression via the PI3K/Akt pathway. Mol Carcinog 55:1772–1785. CrossRefGoogle Scholar
  5. Forrester WC (2002) The Ror receptor tyrosine kinase family. Cell Mol Life Sci 59:83–96CrossRefGoogle Scholar
  6. Fukuda T et al (2008) Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc Natl Acad Sci USA 105:3047–3052. ADSCrossRefGoogle Scholar
  7. Hasan MK et al (2017) Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells. Leukemia. Google Scholar
  8. Hojjat-Farsangi M et al (2013) The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) Cells. PLoS ONE. Google Scholar
  9. Hojjat-Farsangi M, Moshfegh A, Daneshmanesh AH, Khan AS, Mikaelsson E, Osterborg A, Mellstedt H (2014) The receptor tyrosine kinase ROR1-An oncofetal antigen for targeted cancer therapy. Semin Cancer Biol 29:21–31. CrossRefGoogle Scholar
  10. Ida L, Yamaguchi T, Yanagisawa K, Kajino T, Shimada Y, Suzuki M, Takahashi T (2016) Receptor tyrosine kinase-like orphan receptor 1, a target of NKX2–1/TTF-1 lineage-survival oncogene, inhibits apoptosis signal-regulating kinase 1-mediated pro-apoptotic signaling in lung adenocarcinoma. Cancer Sci 107:155–161. CrossRefGoogle Scholar
  11. Kovacs H, Gossert A (2014) Improved NMR experiments with 13C-isotropic mixing for assignment of aromatic and aliphatic side chains in labeled proteins. J Biomol NMR 58:101–112. CrossRefGoogle Scholar
  12. Liu Y, Yang H, Chen T, Luo Y, Xu Z, Li Y, Yang J (2015) Silencing of receptor tyrosine kinase ROR1 inhibits tumor-cell proliferation via PI3K/AKT/mTOR signaling pathway in lung adenocarcinoma. PLoS ONE 10:e0127092. CrossRefGoogle Scholar
  13. Maderegger B, Bermel W, Hrzenjak A, Kostner GM, Sterk H (2002) Solution structure of human apolipoprotein(a) kringle IV type 6. Biochemistry 41:660–668CrossRefGoogle Scholar
  14. Masiakowski P, Carroll RD (1992) A novel family of cell surface receptors with tyrosine kinase-like domain. J Biol Chem 267:26181–26190Google Scholar
  15. Minami Y, Oishi I, Endo M, Nishita M (2010) Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases. Dev Dyn 239:1–15. Google Scholar
  16. Potratz J et al (2016) Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease. Mol Oncol 10:677–692. CrossRefGoogle Scholar
  17. Uhrmacher S, Schmidt C, Erdfelder F, Poll-Wolbeck SJ, Gehrke I, Hallek M, Kreuzer KA (2011) Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL). Leuk Res 35:1360–1366. CrossRefGoogle Scholar
  18. Yu J et al (2016) Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation. J Clin Investig 126:585–598. CrossRefGoogle Scholar
  19. Zhang S et al (2012a) The onco-embryonic antigen ROR1 is expressed by a variety of human cancers. Am J Pathol 181:1903–1910. CrossRefGoogle Scholar
  20. Zhang SP et al (2012b) ROR1 Is expressed in human breast cancer and associated with enhanced tumor-cell growth. PLoS ONE. Google Scholar
  21. Zhang HL et al (2014a) ROR1 expression correlated with poor clinical outcome in human ovarian cancer. Sci Rep. Google Scholar
  22. Zhang SP et al (2014b) Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy. Proc Natl Acad Sci USA 111:17266–17271. ADSCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  1. 1.State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of BotanyChinese Academy of SciencesKunmingPeople’s Republic of China
  2. 2.School of Basic MedicineChengdu University of TCMChengduPeople’s Republic of China

Personalised recommendations